lorazepam has been researched along with clomipramine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Finance, F; Rohmer, F; Ruh-Bernhardt, D; Singer, L | 1 |
| Finance, MF; Ruh, MD; Singer, L | 1 |
| Houa, M; Jaspar, N; Razavi, D; Roman, A; Stevens, E | 1 |
| Adnet, F; Baud, FJ; Bismuth, C; Borron, SW; Finot, MA; Lapostolle, F | 1 |
| Challet, C; Christin, L; von Düring, S | 1 |
2 review(s) available for lorazepam and clomipramine
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for lorazepam and clomipramine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Influence of psychotropic therapy on thrombogenesis and platelet functions. A propos of 4 cases of thromboembolic accidents occurring in patients treated by neuroleptics and antidepressants].
Topics: Aged; Antidepressive Agents; Chlorpromazine; Clomipramine; Female; Humans; Lorazepam; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Tranquilizing Agents | 1976 |
[Pulmonary embolisms occurring in 1 month in 3 aged women with manic-depressive psychoses. Discussion. Etiopathogenic role or psychiatric treatment].
Topics: Aged; Antidepressive Agents; Bipolar Disorder; Chlorpromazine; Clomipramine; Depressive Disorder, Major; Dibenzazepines; Female; Humans; Leg; Lorazepam; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1975 |
Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.
Topics: Anti-Anxiety Agents; Anti-Dyskinesia Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fever; Humans; Lorazepam; Male; Mianserin; Middle Aged; Tetrabenazine | 1998 |
Radiopacity of clomipramine conglomerations and unsuccessful endoscopy: report of 4 cases.
Topics: Acepromazine; Adult; Antidepressive Agents, Tricyclic; Azabicyclo Compounds; Bromazepam; Clomipramine; Gastric Mucosa; Gastroscopy; Humans; Lorazepam; Male; Middle Aged; Piperazines; Poisoning; Prazepam; Pyridines; Radiography; Stomach; Tablets; Zolpidem | 2000 |
Endoscopic removal of a gastric pharmacobezoar induced by clomipramine, lorazepam, and domperidone overdose: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Bezoars; Charcoal; Clomipramine; Delayed-Action Preparations; Domperidone; Drug Overdose; Endoscopy; Female; Humans; Lorazepam; Suicide, Attempted; Treatment Outcome | 2019 |